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Introduction
 
Chronic inflammation, as indicated by the continuous 
presence of serum inflammatory mediators such as C-reactive 
protein (CRP), fibrinogen, and various interleukins, is a risk 
factor for numerous age-related, chronic disorders such as 
diabetes, cardiovascular disease (CVD), cancer, and the 
metabolic syndrome (1, 2), as well as increased frailty and 
cognitive decline (3). Reducing inflammation may help to 
prevent or treat these conditions. Chronic, low-grade 
inflammation, has a complex and multifocal etiology, and may 
be modified by endogenous and exogenous factors. Dietary 
factors have been consistently found to regulate inflammation 
(4-7). Healthy diets (e.g., the Mediterranean diet, rich in fruits 
and vegetables) typically have been associated with lower 
inflammation levels, whereas Western-style diets (e.g., high in 
fat and simple carbohydrate) have been associated with higher 
levels of inflammatory markers (8-11). Specific nutrients such 
as vitamins C, D, and E, beta-carotene, n3-PUFA, flavonoids, 
and other dietary components such as fibre and a moderate 
alcohol intake, have been associated with lower levels of 
inflammation (12, 13). 
The Dietary Inflammatory Index (DII®) was developed to 
estimate the overall inflammatory potential of the diet on an 
anti- to a pro-inflammatory continuum (14). It is derived from 
the literature linking diet and inflammation, incorporating 
cell culture, animal, and human studies. The DII includes 
macronutrients, micronutrients, and other common dietary 
components such as flavonoids and caffeine. Previously, 
the DII has been shown to predict levels of inflammatory 
markers, including CRP and IL-6, in cross-sectional (15-21) 
and longitudinal studies (22). In the Seasonal Variation of 
Blood Cholesterol Study, higher DII scores were associated 
with values of hs-CRP >3 mg/l (OR 1.08; 95 % CI 1.01, 1.16, P 
= 0.035 for the 24HR subset; and OR 1.10; 95 % CI 1.02, 1.19, 
P = 0.015 for the 7-Day Dietary Recall) (16) corresponding 
to an 8% and 10% increase, respectively, in risk for each DII 
point (in a maximum range of about 18 points). In the Women’s 
Health Initiative, the DII was associated with four inflammatory 
biomarkers with beta estimates (95% CI) comparing the highest 
with lowest DII quintiles as follows: interleukin-6: 1.26 (1.15-
1.38), Ptrend < 0.0001; tumour necrosis factor alpha receptor 2: 
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Abstract: Objectives: Chronic low-grade inflammation is a key underlying mechanism in several age-related 
chronic conditions and previous studies have shown that diet can modulate the inflammatory process. We 
investigated the ability of the Dietary Inflammatory Index (DII®), a summary measure of dietary inflammatory 
potential, to predict concentrations of plasma inflammatory markers in a sample of older people. Design: Cross-
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frequency questionnaire), plasma concentrations of inflammatory biomarkers at age 70 (C-reactive protein 
(CRP), fibrinogen) and age 73 (CRP, fibrinogen, hs-CRP, Interleukin-6 (IL-6)). Analyses were performed 
using multivariable logistic regression adjusting for age, sex, smoking, body mass index, physical activity, and 
hypercholesterolaemia. Results: Higher E-DII scores (pro-inflammatory diet) were associated with increased 
odds of elevated CRP (>3mg/L) at age 70 (OR 1.12; 95% CI: 1.02, 1.24, P = 0.02), and elevated IL-6 (>1.6pg/
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provides support for using the DII in research among older populations.
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81.43 (19.15-143.71), Ptrend = 0.004; dichotomized hs-CRP (OR 
for higher vs. lower hs-CRP): 1.30 (0.97-1.67), Ptrend = 0.34; 
and the combined inflammatory biomarker score: 0.26 (0.12-
0.40), Ptrend = 0.0001 (19). Also, the DII has been associated 
with a range of outcomes including several types of cancer (19, 
23-28), cardiovascular disease (29, 30), metabolic syndrome 
(20, 31), and mortality (32-34). Specifically, in the UK, higher 
DII scores were associated with increased risk of recurrent 
depression among women, and all-cause mortality (35, 36). 
Previous validation studies have been conducted among 
young and middle-aged adults in Europe and the US, but not 
among a British population, or in a sample of exclusively older 
adults. Older people tend to have higher levels of systemic 
indicators of chronic inflammation (37). This is often referred 
to as ‘inflammaging’, and is a significant risk factor for 
morbidity and mortality (38). A state of mild or low level 
inflammation is associated with, and predictive of, many aging 
phenotypes such as changes in body composition. Obesity is a 
condition that tends to increase in frequency with age (39) and 
can cause or contribute to inflammaging (40). However, the DII 
has not yet been well-studied in aging populations. It is unclear 
whether associations between the inflammatory potential of diet 
and low-grade systemic inflammation among older adults may 
differ from those observed in younger populations.  Identifying 
pathways that control or ameliorate age-related inflammation 
is important in order to determine whether there are benefits to 
dietary modification, on reducing so-called ‘inflammaging’ and 
adverse health outcomes, at the population level.  
In the present study, our objective was to conduct a 
validation study of food-frequency questionnaire (FFQ)-derived 
DII scores in an older UK sample, The Lothian Birth Cohort 
1936, by evaluating its association with a several inflammatory 
biomarkers (CRP, hs-CRP, fibrinogen, and IL-6). 
Methods
Participants
The Lothian Birth Cohort 1936 (LBC1936) study is a 
longitudinal study of the determinants of normal cognitive 
aging in Scotland, and has been described in detail elsewhere 
(41, 42). Briefly, a total of 1,091 relatively healthy men and 
women about 70 years of age (mean 69.5, sd 0.8), most of 
whom previously participated in the Scottish Mental Survey of 
1947 at age 11, were recruited between 2004 and 2007. All data 
were gathered through interviews, neuropsychological testing, 
blood samples, clinical measurements, and questionnaires, 
by psychologists and medical staff. A total of 866 attended a 
3-year follow-up assessment when they were about 73 years 
old (mean 72.5, sd 0.7). For the current study, we excluded 
ninety-seven participants at age 70, and sixty-nine participants 
at age 73, with CRP and hs-CRP values >10 mg/L to limit 
confounding due to acute infection (43). After exclusions 
and missing data, dietary data and inflammatory biomarker 
data were available for 928 participants at age 70, and 765 
participants at age 73. 
Data collection
Dietary data
Dietary data were collected at baseline using the Scottish 
Collaborative Group 168-item Food Frequency Questionnaire 
(FFQ), version 7.0 (44, 45) reflecting average dietary intake 
over the previous two to three months. Participants were asked 
to indicate how often they consumed each food and drink item 
from a list of frequencies (7+ d/day; 4-6 d/day; 2-3 d/day; 1 d/
day; 4-6 d/week; 2–3 d/week; 1 d/week; 1-3 d/month; rarely 
or never), according to a common unit or portion size. This 
semi-quantitative FFQ was developed for use in older adults. 
In previous studies, the repeatability and validity of the FFQ 
was demonstrated against 4-day weighed food diaries (46, 47). 
Dietary intake in later life was found to be reasonably stable 
in the short term, and the authors reported good validity for 
most nutrients in community-dwelling older populations. FFQ 
responses were used to calculate DII scores for all participants.
Dietary Inflammatory Index
The DII® is a score originally developed using 45 parameters 
(specific foods and nutrients) as indicated by a literature review 
of associations with six inflammatory biomarkers (IL-1β, 
IL-4, IL-6, IL-10, TNFα, and CRP) quantified in around 2000 
peer-reviewed articles. An individual’s DII score, which is 
computed from the FFQ, is compared to food consumption 
data from eleven populations around the world. Details of the 
development (14) and construct validation (16) of the DII have 
been described elsewhere. The overall DII score characterises 
an individual’s diet on a continuum from anti-inflammatory (the 
low end of the scale) to pro-inflammatory (the high end of the 
scale). The DII score can be calculated using >20 items from 
the desired list of food parameters. In the LBC1936 study, 26 
parameters were available for inclusion in the overall DII score, 
namely: energy; carbohydrate; protein; total fat; saturated fat; 
cholesterol; iron (which contribute positively to the calculation 
of the overall DII score), and polyunsaturated fat; fibre; 
thiamine; riboflavin; vitamins B6, B12, C, D, E; zinc; selenium; 
folic acid; beta-carotene; flavonol; flavonones; flavones; 
alcohol; tea; and total caffeine (which contribute negatively to 
the calculation of the overall DII score). The dietary parameter 
values were summed to create an overall DII score. To control 
for the effect of total energy intake, we calculated the energy-
adjusted version of the DII per 1,000 calories of food consumed 
(the E-DII), using the energy-standardized version of the world 
database. All calculations in the current study were performed 
according to standard DII protocol (14).
Inflammation biomarkers
Blood samples were drawn from participants at age 70-wave 
1 (baseline) and at a 3-year follow-up at age 73-Wave 2, by a 
qualified nurse, immediately centrifuged, and stored frozen at 
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-80°C. Serum CRP (mg/l) and fibrinogen (g/l) concentrations 
were measured at ages 70 and 73. High-sensitivity CRP 
(hs-CRP mg/l) and IL-6 (pg/l) concentrations were measured at 
age 73 only. 
The (non-hs) CRP assay was performed using a dry-
slide immuno-rate method on OrthoFusion 5.1 F.S analysers 
(Ortho Clinical Diagnostics). The CRP assay method has low 
sensitivity in the lower range of CRP values; approximately 
45% of participants were in the single lowest category (1.5 
mg/l). The fibrinogen assay was performed using an automated 
Clauss assay (TOPS coagulometer; Instrumentation Laboratory, 
Warrington, UK). Hs-CRP and IL-6 were determined using 
high-sensitivity enzyme-linked immunosorbent assay kits 
(R&D Systems, Oxon, UK).
Covariates
Data including education (years of full-time formal 
schooling), smoking status (current, ex- or never), and history 
of disease (hypertension, CVD, hypercholesterolaemia, stroke, 
and diabetes) were collected at interview. Data on physical 
activity (number of days per average month doing any sport 
or physical exercise that makes you out of breath and sweat 
Table 1
Dietary parameters used in the calculation of the energy-adjusted Dietary Inflammatory Index (E-DII) across the tertiles of the 
E-DII at baseline (Mean scores and standard deviations)
Tertiles of Dietary Inflammatory Index (E-DII) 
Tertile 1 
(n 309)
Tertile 2 
(n 310)
Tertile 3 
(n 309)
Dietary parameter m sd m sd m sd P
E-DII scores -0.13 0.83 0.64 0.42 2.37 0.76 <0.001
Energy, kcal 7711.62 3109.30 8073.46 2714.42 8447.17 2703.82 0.006
Carbohydrates, g 108.78 49.26 115.06 45.53 123.94 52.05 0.001
Protein, g 76.21 28.59 75.19 25.41 74.74 26.91 0.79
Alcohol, g 8.518 10.05 12.91 18.83 14.51 19.29 <0.001
Fibre, g 19.74 10.58 15.74 5.92 13.23 5.26 <0.001
Cholesterol, mg 248.64 110.47 279.02 108.23 318.00 137.02 <0.001
Saturated fat, g 23.88 11.93 28.83 11.61 34.05 14.24 <0.001
PUFA, g 11.81 6.03 11.87 5.09 10.77 4.35 0.01
Thiamin, mg 1.62 0.67 1.52 0.56 1.46 0.57 0.004
Riboflavin, mg 1.95 0.81 1.98 0.90 1.94 0.80 0.84
Vitamin B6, mg 2.22 0.92 2.05 0.78 1.88 0.71 <0.001
Vitamin B12, μg 6.79 3.36 6.77 3.80 6.44 3.00 0.35
Vitamin C, mg 145.46 96.16 104.36 50.18 76.15 40.15 <0.001
Vitamin D, μg 4.39 2.76 4.23 3.09 3.74 1.98 0.007
Vitamin E, mg 9.20 5.55 8.20 4.08 6.99 3.14 <0.001
Iron, mg 13.06 5.35 12.37 4.39 11.63 4.09 0.001
Zinc, mg 9.13 3.80 8.90 3.35 8.82 3.59 0.53
Selenium, μg 52.54 22.81 48.93 24.16 45.06 17.00 <0.001
Folic acid, μg 306.96 128.60 273.79 95.07 250.20 86.47 <0.001
Beta-carotene, μg 4171.05 3973.60 2569.19 1338.44 1844.46 925.39 <0.001
Flavonols, mg 41.12 22.55 39.57 25.43 32.62 27.25 <0.001
Flavonones, mg 34.68 28.40 25.72 24.73 15.56 19.31 <0.001
Flavones, mg 0.33 0.30 0.29 0.19 0.26 0.16 <0.001
Tea, g 2.66 1.86 2.71 2.12 2.25 2.20 0.01
Caffeine, g 183.40 102.63 190.65 109.92 176.93 97.96 0.26
Continuous variables are presented as mean values and standard deviations; E-DII, energy-adjusted dietary inflammatory index; KJ, kilojoules; PUFA, polyunsaturated fatty acids; Higher 
E-DII scores indicate a pro-inflammatory diet; P values obtained using ANOVA. 
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Table 2
   Participant characteristics across the tertiles of the energy-adjusted Dietary Inflammatory Index (E-DII) at age 70 (wave 1)  
and age 73 (wave 2) (Mean scores, or number of participants and percentages)
Tertiles of Dietary Inflammatory Index (E-DII)
Age 70 (n 928) Age 73 (n 765)
Tertile 1  
n 309
Tertile 2  
n 310
Tertile 3  
n 309
Tertile 1  
n 256
Tertile 2  
n 255
Tertile 3  
n 254
Characteristics m or n(%) m or n(%) m or n(%) P m or (%) m or (%) m or (%) P
E-DII score -0.13 0.64 2.37 <0.001
Sex <0.001
   Men 103 (33.3) 151 (48.7) 196 (63.4)
   Women 206 (66.7) 159 (51.3) 113 (36.6)
Education (years) 10.81 10.83 10.74 0.64
Age (years) 69.54 69.46 69.50 0.57 72.51 72.44 72.48 0.52
Depression (HADS-D) 2.51 2.79 2.87 0.10 2.29 2.63 2.72 0.06
CRP mg/l 0.03 0.29
   Normal ≤3mg/l 174 (58.0) 156 (51.5) 140 (46.8) 151 (66.2) 131 (59.5) 134 (62.6)
   Elevated >3mg/l 126 (42.0) 147 (48.5) 159 (53.2)   77 (33.8)   89 (40.5)   80 (37.4)
Fibrinogen, g/l 3.28 3.29 3.27 0.96 3.32 3.31 3.33 0.91
   Normal ≤4.0g/l 262 (87.3) 251 (83.1) 258 (86.0) 203 (84.6) 211 (87.2) 207 (85.9)
   Elevated >4.0g/l 38 (12.6) 51 (16.9) 42 (14) 37 (15.4) 31 (12.8) 34 (14.1)
hs-CRP mg/l† 1.79 2.06 2.17 0.09
   Normal ≤3mg/l 189 (81.5) 176 (76.5) 171 (75.3)
   Elevated >3mg/l   43 (18.5)   54 (23.5)   56 (24.7)
IL-6 pg/l† 1.82 1.90 2.21 0.02
   Normal ≤1.6pg/l 143 (59.8) 126 (51.7) 114 (47.3)
   Elevated >1.6pg/l 96 (40.2) 114 (47.5) 127 (52.7)
Physical activity (days/month) 8.37 7.76 6.68 0.03
BMI kg/m2 27.44 27.73 27.64 0.68 27.68 27.65 27.67 1.00
   Normal (<25) 88 (28.8)   74 (23.9)   73 (23.9)   60 (23.7)   59 (23.4)   68 (27.0)
   Overweight (25 to <30) 147 (48.0) 154 (49.8) 146 (47.9) 136 (53.8) 128 (50.8) 111 (44.0)
   Obese (≥30) 71 (23.2)   81 (26.2)   86 (28.2)   57 (22.5)    65 (27.8)   73 (29.0)
Smoking status, <0.001 <0.001
   non-smoker 157 (50.8) 148 (47.7) 130 (42.1) 130 (50.8) 126 (49.4) 115 (45.3)
   ex-smoker 138 (44.7) 141 (45.5) 116 (37.5) 117 (45.7) 116 (45.5)   99 (39.0)
   current smoker   14 (4.5)   21 (6.8)   63 (20.4)      9 (3.5)    13 (5.1)   40 (15.7)
Hypertension, n (%) 0.83 0.30
   Yes 126 (40.8) 121 (39.0) 119 (38.5) 126 (49.2) 116 (45.5) 133 (52.4)
   No 183 (59.2) 189 (61.0) 190 (61.5) 130 (50.8) 139 (54.5) 121 (47.6)
CVD, n (%)    0.27 0.62
   Yes 73 (23.6) 65 (21.0) 82 (26.5) 74 (28.9) 66 (25.9) 75 (29.5)
   No 236 (76.4) 245 (79.0) 227 (73.5) 182 (71.1) 189 (74.1) 179 (70.5)
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for >20 minutes at a time) and depression (derived from the 
Hospital Anxiety and Depression Scale, HADS-D; (48)) were 
collected using questionnaires. The HADS-D score ranges 
from 0 to 21 with lower scores indicating fewer depressive 
mood symptoms. Body mass index (BMI) was derived from 
height and weight measures taken by a nurse during the clinical 
assessment and calculated as kilograms per metre squared. 
Statistical analysis
All inflammation biomarkers were categorised according 
to conventional and clinically relevant cut-off points. In the 
main analyses, as in previous LBC1936 studies (49, 50) and 
other DII validation studies (e.g. 15-17, 19, 22), all CRP values 
were dichotomised at the level of 3 mg/l: normal (3 mg/l or 
less) and elevated (greater than 3 mg/l). The relevance of the 3 
mg/l cut-off has been implicated in the prediction of CVD (43). 
Fibrinogen values were dichotomised at the level of 4.0 g/l: 
normal (4.0 g/l or less) and elevated (greater than 4.0 g/l) in line 
with the standard UK clinical reference range. IL-6 values were 
dichotomised at the detection level of 1.6 pg/ml: normal (1.6 
pg/ml or less) and elevated (greater than 1.6 pg/ml). This cut-
off level is consistent with a previous DII validation study (17). 
For descriptive purposes, participants’ characteristics were 
summarised according to E-DII tertiles using frequencies (n 
Table 2 (continued)
   Participant characteristics across the tertiles of the energy-adjusted Dietary Inflammatory Index (E-DII) at age 70 (wave 1)  
and age 73 (wave 2) (Mean scores, or number of participants and percentages)
Tertiles of Dietary Inflammatory Index (E-DII)
Age 70 (n 928) Age 73 (n 765)
Tertile 1  
n 309
Tertile 2  
n 310
Tertile 3  
n 309
Tertile 1  
n 256
Tertile 2  
n 255
Tertile 3  
n 254
Characteristics m or n(%) m or n(%) m or n(%) P m or (%) m or (%) m or (%) P
Hypercholesterolaemia, n (%) 0.046 0.05
   Yes 125 (40.5) 106 (34.3) 96 (31.1) 119 (46.5) 106 (41.6) 91 (35.8)
   No 184 (59.5) 203 (65.7) 213 (68.9) 137 (53.5) 149 (58.4) 163 (64.2)
Stroke, n (%) 0.84 0.94
   Yes 13 (4.2) 15 (4.8) 12 (3.9) 16 (6.2) 17 (6.7) 15 (5.9)
   No 296 (95.8) 295 (95.2) 297 (96.1) 240 (93.7) 238 (93.3) 239 (94.1)
Diabetes, n (%) 0.58 0.99
   Yes 24 (7.8) 27 (8.7) 20 (6.5) 25 (9.8) 24 (9.4) 25 (9.8)
   No 285 (92.2) 283 (91.3) 289 (93.5) 231 (90.2) 231 (90.6) 229 (90.2)
Continuous variables are presented as mean values (and P values) and categorical variables are presented as numbers (and percentages); DII, dietary inflammatory index; HADS-D, 
Hospital Anxiety and Depression Score-Depression sub-test; MMSE, Mini-mental State Examination; CRP, C-reactive protein; IL-6, Interleukin-6; CVD, cardiovascular disease; †hs-CRP 
and IL-6 data were unavailable at age 70; P-values obtained using X2 tests or ANOVA tests, as appropriate.
Table 3
Associations between the Dietary Inflammatory Index (E-DII) scores at baseline (age 70) and inflammation biomarkers as cate-
gorical variables at baseline and 3-year follow-up (ORs, and 95% confidence intervals)
               Model 1                                    Model 2
Biomarker OR 95% CI P OR 95% CI P
Age 70
  Fibrinogen (>4g/l) 1.000 0.999, 1.001 0.70 0.983 0.870, 1.110 0.78
  CRP (>3mg/l) 1.148 1.049, 1.257 0.003 1.122 1.018, 1.237 0.02
Age 73
  Fibrinogen (>4g/l) 0.953 0.833, 1.087 0.46 1.111 0.967, 1.276 0.14
  CRP (>3mg/l) 1.066 0.964, 1.180 0.21 0.943 0.847, 1.050 0.28
  hs-CRP (>3mg/l) 1.082 0.965, 1.213 0.18 0.964 0.852, 1.091 0.56
  IL-6 (>1.6pg/l) 1.131 1.031, 1.242 0.009 1.112 1.004, 1.231 0.04
CRP, C-reactive protein; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin-6; Model 1: adjusted for age, sex; Model 2: adjusted for age, sex, BMI, smoking status, physical 
activity, hypercholesterolaemia.
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(%)) for categorical variables and means ± standard deviations 
for continuous variables. Comparison of participants’ 
characteristics across the E-DII tertiles were made using 
Chi-square tests for categorical variables and ANOVA for 
continuous variables. Normality of the distribution was assessed 
using Q-Q plots and the Kolmogorov-Smirnov test.
The associations between E-DII scores (as a continuous 
variable) and each inflammation biomarker available at age 
70 and age 73 were analysed using multivariable logistic 
regression models. Model 1 was fit for each inflammation 
biomarker as the dependent variable and a continuous measure 
of the E-DII as the predictor variable, adjusting for age (exact 
age in days at the time of testing) and sex. Model 2 adjusted 
for multiple covariates, namely, age, sex, smoking status 
(current, ex, never), body mass index, physical activity, and 
hypercholesterolaemia. Models were not adjusted for total 
energy intake because it is one of the DII components and 
was accounted for in the formulation of the E-DII scores. All 
analyses were performed using SPSS software (version 23). A 
P-value of < 0.05 was considered significant.
Results
Table 1 presents the dietary parameters used to calculate 
the E-DII across the E-DII tertiles. Higher E-DII scores 
(indicating a more pro-inflammatory diet) were associated 
with a significantly higher intake of calories, carbohydrates, 
alcohol, cholesterol and saturated fat. Conversely, there were 
significant and linear inverse associations between the E-DII 
and intake of fibre, flavonoids, and various specific nutrients 
(thiamine, vitamins B6, C, D, E, iron, selenium, folic acid and 
beta-carotene). These associations were all in the expected 
direction for the DII, with the exception of iron. Non-significant 
associations were observed between the E-DII score and 
protein, riboflavin, vitamin B12, zinc, and total caffeine.
Table 2 shows characteristics of the study participants at 
both time-points (age 70 and age 73) across the E-DII tertiles. 
The E-DII ranged from -3.82 to 5.01, with a mean of 0.59 (sd 
1.63) which is slightly pro-inflammatory. Overall, participants 
in the highest tertile of E-DII scores (i.e., those with a pro-
inflammatory diet) were more likely to be male, current 
smokers, less physically active, and less likely to have a history 
of hypercholesterolaemia, compared to those in tertiles 1 and 2. 
E-DII scores were not associated with chronic disease outcomes 
with the exception of hypercholesterolaemia (P = 0.046), such 
that a history of high cholesterol was associated with a lower 
E-DII (indicative of an anti-inflammatory diet). 
Men and women did not differ in their concentrations of 
inflammation biomarkers. Elevated CRP concentrations (>3 
mg/l) were found in 47.9% (n 432) of participants at wave 1 
(age 70) and 37.2% (n 246) of participants at wave 2 (age 73); 
the correlation between non-hs-CRP at both time-points was r = 
0.27 (P < 0.001). Elevated fibrinogen concentrations (> 4.0g/l) 
were found in 14.5% (n 131) at age 70 and 14.1% (n 102) at age 
73; the correlation between fibrinogen at both time-points was 
r = 0.50 (P < 0.001). Elevated hs-CRP was found in 22.2% (n 
153) of participants when measured a wave 2 (age 73). At age 
73, the correlation between CRP and hs-CRP at age 73 was r 
= 0.80 (P < 0.001). Elevated IL-6 concentrations (> 1.6pg/l) 
were found in 46.8% (n 337) of participants at age 73. The 
correlation between hs-CRP and IL-6 at age 73 was r = 0.43 (P 
< 0.001). 
Table 3 presents the results of multivariable logistic 
regression models. In the fully adjusted model, higher 
E-DII scores were significantly associated with higher CRP 
concentrations measured at age 70 (OR; 1.12, 95% CI 1.02, 
1.24, P = 0.02) and higher IL-6 concentrations at age 73 
(OR; 1.12, 95% CI 1.0042, 1.23, P = 0.04). No significant 
associations were observed between the E-DII and fibrinogen. 
Post-hoc analyses (data not presented) showed that the 
statistically significant associations between E-DII scores and 
elevated CRP (age 70) and IL-6 (age 73) were strongest when 
comparing the highest tertile of the E-DII with the lowest 
(reference group, tertile 1). The odds of having an elevated CRP 
value (>3mg/l) for those in the highest E-DII tertile was 1.63 
(95% CI 1.14, 2.35, Ptrend = 0.008) times greater compared to 
those in lowest E-DII tertile. The odds of having an elevated 
IL-6 value (>1.6 pg/l) for those in the highest tertile of the 
E-DII was 1.60 (95% CI 1.11, 2.33, Ptrend = 0.01) times greater 
than those in the lowest E-DII tertile.
Discussion
This study found that higher E-DII scores were significantly 
associated with increased odds of having elevated plasma 
CRP and IL-6 among a sample of Scottish men and women 
in their seventies. Validation provides support for using the 
DII to predict systemic inflammation in later life. Our results 
suggest that a pro-inflammatory diet (high in cholesterol and 
saturated fats), and relatively lacking in anti-inflammatory 
foods (fruits and vegetables), is associated with significantly 
higher concentrations of two inflammatory biomarkers.
To the best of our knowledge, this is the first time that 
the DII has been validated in a sample of UK-based, and 
exclusively older, individuals. Previously, the DII has been 
validated in several US (16, 17, 19-21) and European (18, 22) 
populations. We observed significant associations when CRP 
was examined contemporaneously with E-DII at age 70, yet 
associations between baseline (age 70) E-DII scores and CRP 
and hs-CRP at age 73, were absent. Longitudinal studies of 
the DII are lacking. However, in the SU.VI.MAX cohort in 
France, the DII was not associated with CRP at a long-term 
(12-year) follow-up (22). Although statistical significance was 
not reached, associations between the E-DII and hs-CRP (CRP 
using the high-sensitivity procedure) in the present study, were 
linear and in the expected direction (with slightly smaller effect 
sizes). Comparable findings of non-significant associations 
have been reported in other studies investigating DII in relation 
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to hs-CRP (17, 51). Associations between E-DII and fibrinogen 
were non-significant at both time-points. Unlike CRP and 
IL-6, there was no linear association between fibrinogen 
concentrations and E-DII score. Furthermore, there was little 
variance in plasma fibrinogen concentrations at each wave of 
testing, and little variation in change over time, limiting the 
ability to detect meaningful associations.  However, some 
research indicates that hs-CRP and fibrinogen are less sensitive 
indicators of prevalent CVD, and CVD risk, than IL-6 (52). 
Overall, our results are concordant with those of the 
Asklepios study (17) which found significant associations 
with IL-6 but no association between E-DII and hs-CRP or 
fibrinogen. Of the various markers of systemic inflammation, 
it appears that IL-6 is particularly relevant to aging. A review 
by Singh & Newman concludes that, of the inflammatory 
markers examined in cohort studies of aging, IL-6 is most 
robustly related to multiple disease outcomes, including CVD, 
diabetes, cancer, as well as disability and mortality (37). 
Mirroring this, clinical investigations have moved ‘upstream’ 
in the inflammatory cascade from CRP to IL-6 (and IL-1). 
There is increasing evidence that IL-6 ‘drives’ downstream 
inflammatory markers such as CRP and fibrinogen (53, 54), and 
as such, interleukins have been identified as more promising 
targets for intervention in atheroprotection (55).
This study also found that higher E-DII scores were 
associated with a range of unhealthy aging phenotypes. 
Those participants with a higher E-DII were more likely to 
be current smokers and less physically active. Smoking status 
was significantly and strongly associated with E-DII at both 
time-points and had a marked attenuating effect in the models. 
Chronic smoking induces the release of pro-inflammatory 
markers including IL-6 and acute-phase proteins and decreases 
the production of anti-inflammatory cytokines (56). Though 
physical exercise causes an acute-phase elevation of IL-6, in the 
long-term, regular physical activity has an anti-inflammatory 
effect via multiple pathways including cytokine production, 
improved endothelial function, and insulin sensitivity (57). 
Several other associations; e.g., with BMI, education and 
depression scores, were in the expected direction, in line with 
similar research, though not statistically significant. Thus, 
higher E-DII scores were found among those with a higher 
BMI, less education, and more symptoms of depression. The 
lack of a statistically significant association with BMI in this 
study is in contrast to many others which have examined DII in 
relation to BMI or obesity (e.g. 15, 58). There are two plausible 
explanations for this finding. First, by using BMI, we are 
examining the effect of overall obesity. However, other findings 
suggest that abdominal or ‘central’ obesity (in both obese and 
non-obese adults) is a specific contributor to inflammation (59, 
60). Second, the predictive ability of BMI changes over time. 
Midlife obesity (related to the emergence of conditions such 
as hypertension) is related to higher risk of CVD, dementia 
and other outcomes, whereas it is not at older ages (61, 62). In 
fact, high BMI in later life (over the age of 65 years) becomes a 
predictor of decreased morbidity and mortality (63, 64).   
The E-DII in our sample was not related to conditions 
such as CVD, stroke, diabetes or hypertension, despite 
the vast literature linking the DII with these conditions 
and their risk factors (see 65). Interestingly, a history of 
hypercholesterolaemia was associated with having lower 
E-DII scores. It is plausible that dietary modification, a first-
line treatment strategy for elevated cholesterol levels, has 
lowered the inflammatory potential of the diet in those affected. 
Short-term improvements in DII scores have previously been 
observed among a sample of overweight and obese adults, in 
those randomised to plant-based diets, relative to those in the 
control (omnivore) group (66).  
Overall, our study results are consistent with the hypothesis 
that diet modulates inflammation. Food items that tend to 
increase E-DII scores include butter, other animal fats, and 
high-fat sweets. Higher scores also could result from low 
consumption of food items considered to be anti-inflammatory 
such as fruits, vegetables and juices (18). Dietary characteristics 
unique to an older generation in Scotland, such as a higher 
intake of meat and saturated fat, and low intake of fresh 
produce (67), may explain some differences with other studies. 
Scotland’s unhealthy diet is widely cited as a factor in its’ poor 
health record (68). Of course, food choices in later life may be 
affected by illness, dental problems, gastrointestinal disorders 
and other aging issues. Although there are issues inherent in 
examining diet in an older population, our results suggest that 
the DII is a useful instrument for predicting inflammation 
biomarkers in later life.   
This was the first study to validate the DII in a UK 
population, and in an exclusively older sample. Therefore, it has 
an important place in a growing area of academic enquiry.  This 
manuscript also serves as a stepping stone for future papers in 
the same cohort. One of the strengths of the present study is the 
use of a validated and reproducible FFQ, which allowed for a 
comprehensive assessment of major nutrient sources in the diet. 
Other strengths include the availability of a range of covariates 
and two waves of data. 
Limitations of this study include the non-availability of 
IL-6 and a high-sensitivity measure of CRP at baseline. Some 
measurement error inherent in the FFQ may be present; the 
list of foods is finite, portion sizes are estimates only, and 
self-reports may be biased. Although validated, the SCG-
FFQ did not allow for the inclusion of all 45 food parameters 
required for optimal calculation of the DII. However, despite 
the reduction in the number of parameters, we still were 
able to successfully observe associations with some of the 
inflammatory markers, as have previous validation studies 
which have used fewer, e.g., the Asklepios study (17). It is 
possible that multiple testing may have resulted in chance 
associations being declared significant. In view of this, further 
replication is required. The DII score, calculated here from 26 
components, ranged from -3.82 to 5.01. The lower (less pro-
inflammatory) end of the continuum was less well represented 
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in the LBC1936 than in other studies (e.g., 16, 19). Changes in 
the inflammatory potential of diet over time were not accounted 
for because only baseline dietary data were used to calculate 
the E-DII. There are many factors which determine serum 
concentrations of CRP, IL-6, and other cytokines, such as 
medical conditions and medications. We modelled the data 
on all the available potential confounders, but acknowledge 
the non-availability of medications data in the current study, 
including the pharmacological treatment of inflammation. 
A lower percentage of participants in the elevated CRP 
group at age 73, compared with age 70, could reflect a 
healthy survivor effect in this aging cohort. Those with more 
pro-inflammatory diets, and higher levels of inflammation 
biomarkers, may suffer from health consequences in later 
life that preclude them from taking part in the study. Given 
that our sample comprised relatively healthy volunteers from 
an affluent area of Scotland, the findings may have limited 
generalisability. However, the most likely result of this, is a 
modest underestimation of the effect sizes of the associations 
present.  
Conclusions
In this study, E-DII scores were positively associated with 
CRP and IL-6 concentrations among an older-adult sample 
in Scotland. Validation of the E-DII  further supports its use 
in assessing the potential impact of diet on inflammatory 
processes and extends the generalisability of this tool to an 
older (and British) population. Confirmation of these findings 
is warranted in order to further substantiate the utility of the 
DII to help in informing dietary intervention among an older 
population at risk of chronic disease. 
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